Search research articles
Contact Us
Filters
Showing results (11-20 of 126) with videos related to
Page
of 13
Sort By:
The New England Journal of Medicine
|
September 16, 2020
Liraglutide for Adolescents with Obesity
Markus S Anker, Javed Butler, Stefan D Anker
Journal of Cachexia, Sarcopenia and Muscle
|
December 19, 2020
Blocking myostatin: muscle mass equals muscle strength?
Markus S Anker, Stephan von Haehling, Jochen Springer
European Heart Journal
|
January 30, 2026
The EMPATICC-trial-should location shape therapy?
Markus S Anker, Stefan D Anker, Tienush Rassaf
The New England Journal of Medicine
|
November 9, 2018
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
Markus S Anker, Wilhelm Haverkamp, Stefan D Anker
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
October 27, 2016
Advances in cachexia and sarcopenia research in the heart failure context: call for action
Jochen Springer, Markus S Anker, Stefan D Anker
Journal of the American College of Cardiology
|
July 5, 2023
Understanding Who Responds to M-TEER in Heart Failure With SMR: Malnutrition Does Not Preclude Benefit
Markus S Anker, Stephan von Haehling, Ulf Landmesser
The New England Journal of Medicine
|
December 4, 2023
Ferric Carboxymaltose in Heart Failure with Iron Deficiency
Stefan D Anker, Gerasimos Filippatos, Markus S Anker
The New England Journal of Medicine
|
April 15, 2026
Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes
Markus S Anker, Javed Butler, Stefan D Anker
Journal of Cachexia, Sarcopenia and Muscle
|
November 29, 2016
Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016
Stephan von Haehling, Markus S Anker, Stefan D Anker
ESC Heart Failure
|
December 31, 2019
The difference in referencing in Web of Science, Scopus, and Google Scholar
Markus S Anker, Sara Hadzibegovic, Alessia Lena, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 126) with videos related to
Sort By:
Page
of 13
The New England Journal of Medicine
|
September 16, 2020
Liraglutide for Adolescents with Obesity
Markus S Anker, Javed Butler, Stefan D Anker
Journal of Cachexia, Sarcopenia and Muscle
|
December 19, 2020
Blocking myostatin: muscle mass equals muscle strength?
Markus S Anker, Stephan von Haehling, Jochen Springer
European Heart Journal
|
January 30, 2026
The EMPATICC-trial-should location shape therapy?
Markus S Anker, Stefan D Anker, Tienush Rassaf
The New England Journal of Medicine
|
November 9, 2018
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
Markus S Anker, Wilhelm Haverkamp, Stefan D Anker
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
October 27, 2016
Advances in cachexia and sarcopenia research in the heart failure context: call for action
Jochen Springer, Markus S Anker, Stefan D Anker
Journal of the American College of Cardiology
|
July 5, 2023
Understanding Who Responds to M-TEER in Heart Failure With SMR: Malnutrition Does Not Preclude Benefit
Markus S Anker, Stephan von Haehling, Ulf Landmesser
The New England Journal of Medicine
|
December 4, 2023
Ferric Carboxymaltose in Heart Failure with Iron Deficiency
Stefan D Anker, Gerasimos Filippatos, Markus S Anker
The New England Journal of Medicine
|
April 15, 2026
Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes
Markus S Anker, Javed Butler, Stefan D Anker
Journal of Cachexia, Sarcopenia and Muscle
|
November 29, 2016
Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016
Stephan von Haehling, Markus S Anker, Stefan D Anker
ESC Heart Failure
|
December 31, 2019
The difference in referencing in Web of Science, Scopus, and Google Scholar
Markus S Anker, Sara Hadzibegovic, Alessia Lena, et al.
Page
of 13